Ask Our Experts - Intertek Pharmaceutical Services
Ask Our Experts! - Contact our experts directly with your technical and commercial questions concerning COVID-19 vaccine, therapeutic or diagnostic development support
Mark Parry, Technical Director
Mark has nearly 20 years’ experience working within the pharmaceutical analysis and formulation development industry, with a particular focus on OINDPs. Mostly working in the pre-approval stages, Mark’s background includes extensive experience with product and formulation development for novel and generic products, as well as method development and validation, stability studies, pharmaceutical development activities, and clinical trial manufacturing for a wide range of clients.
Ashleigh Wake, Business Development Director
Ashleigh has held technical and operational management roles in Zeneca, AstraZeneca and Syngenta before joining Intertek. She has a 20 year career as an operational / technical team leader and study director and has specialized in the delivery of GXP studies on biopharma structure, physiochemical and biological activity. She is currently responsible for strategic growth and business development at Intertek’ centre of excellence for biologics characterisation in the UK.
John Todd, Business Development Director
John has held commercial and management roles in several technology companies. He joined Intertek in 2015 and has been responsible for business development, account management, and stewardship of new and existing partnerships. He routinely works with global companies to design tailored outsourcing contracts to meet their technical and commercial needs and has presented at conferences on outsourcing models for the biopharma sector.
Jun - WEBINAR: Glycoslyation using Site Specific Approaches fro Antibody-based Therapies
Jun - ARTICLE: A Strategic Approach for Nitrosamine Impurity Screening
Jun - WEBINAR: Characterization and Quantification by NMR
Jun - WEBINAR: Design of Extractables and Leachables Studies
May - NEW: COVID-19 - Ask Our Experts Platform Launched
May - ARTICLE: Repurposing Vaccines for Intranasal Development
May - WEBINAR: Quality Control Strategy for Vaccine Development
May - eBOOK: Contingency Outsourcing Solutions
May - WEBINAR: Repurposing Products for Inhaled Delivery
Apr - ARTICLE: Nebulised Drug Development Considerations
Apr - ARTICLE: CMC Considerations for mRNA Based Therapies
Visit us: Conferences & Events
NEW: Immediate Question? ASK OUR EXPERTS NOW
FACTSHEET: COVID-19 Vaccine and Therapeutic Testing and Development Outsourcing Solutions
ARTICLE: Repurposing Vaccines for Intranasal Development
WEBINAR: Quality Control Strategy for Vaccine Development
WEBINAR: Repurposing Products for Inhaled Delivery - Rapid Response Strategies
eBOOK: Contingency Outsourcing Solutions
LEARN MORE